Christopher J. Sobecki - Apr 28, 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Christopher J. Sobecki
Stock symbol
LXRX
Transactions as of
Apr 28, 2024
Transactions value $
$0
Form type
4
Date filed
4/29/2024, 04:20 PM
Previous filing
May 31, 2023
Next filing
May 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise $0 +8.03K +5.05% $0.00 167K Apr 28, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise $0 -8.03K -100% $0.00* 0 Apr 28, 2024 Common Stock 8.03K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.